Whether a balm causes spots, and how to find out for your own skin
The 0 to 5 charts come from rabbit ear tests on single raw materials. A finished balm behaves differently, and a four week half face trial beats any chart.
A balm stays on the skin longer and in greater quantity than almost anything else in a routine, so the question is a fair one. The way it normally gets answered is not: a chart of numbers between 0 and 5, generated on animal tissue from neat raw materials, for a screening purpose almost nobody who quotes it remembers. This page sets out what actually makes a spot, which balm ingredients have real published support behind their reputations, and how to settle the question on your own face in four weeks.
Usually not, and no ingredient chart can tell you. Ratings come from rabbit ear tests on neat materials, and finished products built from rated ingredients are frequently not comedogenic in human testing. The only answer that applies to you comes from a four week trial: one facial area, a fixed dose, one change at a time, photographs at day 0, day 14 and day 28.
The chart on your screen was made on a rabbit's ear
The 0 to 5 comedogenic scale is not a fraud and it is not a measurement of your face. It came from work between 1972 and 1989 in which candidate cosmetic materials were applied repeatedly to the external ear of a rabbit, a site chosen precisely because its follicles plug fast and reproducibly, and the resulting follicular keratosis was graded under a microscope. It was a screening tool for formulators deciding whether to put an ester into a foundation. The full provenance, including the compiled 1989 ingredient list that essentially every chart in circulation descends from, is laid out in comedogenic ratings.
Three features of that assay explain why the number on a chart does not transfer to the tin in your hand. Materials were tested neat or close to it, while a balm might contain the same material at 6 percent. Application was repeated and occluded on tissue selected for sensitivity, and the assay was deliberately built to be over-sensitive so that it would not miss a genuine offender. And the endpoint was microscopic plugging in an animal, not a visible spot on a person.
The finding that should have ended the argument came in 2006, when Draelos and DiNardo tested finished formulations on human volunteers with prominent follicular openings and reported that products made with comedogenic ingredients are not necessarily comedogenic. A rating describes a raw material under laboratory stress. A balm is a solution of that material in other fats, applied thinly, by you, in your climate. The two are different objects, and the second is the one that matters.
What actually causes a spot
Acne is not a plumbing problem in which grease drops into a hole. Four processes run together in the pilosebaceous unit, and no wax simply blocks any of them.
The first is follicular hyperkeratinisation: the cells lining the neck of the follicle stop shedding cleanly and pile up, narrowing the channel from the inside. That plug, mixed with sebum, is the microcomedo, and every visible lesion starts as one. The second is sebum, which is produced by the sebaceous gland under androgen control and is not the same substance as the oil you apply. Sebum composition matters as much as volume, with squalene and its oxidation products implicated in the inflammatory side. The third is Cutibacterium acnes, a normal resident that becomes relevant when particular strains proliferate in the anaerobic, lipid-rich environment of a blocked follicle. The fourth is inflammation, which the current literature places early rather than late: inflammatory mediators are detectable in skin that has not yet produced a visible comedo.
Read that list back and notice what a topical fat can and cannot do. It cannot enter the sebaceous gland and turn up sebum production. What it can plausibly do is change the local environment at the follicular opening, supply substrate for lipid-dependent organisms, or irritate the follicle directly. Those are three distinct routes with three distinct appearances, which is why the single question "is it comedogenic" is the wrong question.
Three reactions, three timelines
Almost all the confusion in this subject comes from treating every spot that appears after a new product as the same event. They are not, and the timing separates them better than any ingredient list.
| Reaction | What you see | Appears in | Distribution |
|---|---|---|---|
| Comedogenic response | Closed comedones and blackheads, little or no redness at first, skin feels bumpy before it looks wrong | 3 to 8 weeks | Exactly where the product sits, and nowhere else |
| Acnegenic response | Inflamed papules and pustules with few comedones, arriving faster than comedones can physically form | 3 to 10 days | Where applied, often patchy |
| Irritant folliculitis | Uniform pustules with stinging or burning, sometimes redness in the skin between follicles | 24 to 72 hours | Sharply bordered, matching the application area |
| Malassezia folliculitis | Itchy, monotonously similar small papules and pustules, no blackheads at all | 2 to 6 weeks | Forehead, hairline, chest and upper back, often beyond where you applied |
| Allergic contact reaction | Itch, redness, scaling, sometimes small papules that resemble acne | 24 to 96 hours after re-exposure | Application area, spreading at the edges |
The practical value of that table is what it rules out. Something that flared in three days is not a comedogenic response, because a comedo cannot form that quickly. Something itchy, uniform and spreading to your chest is worth reading about in malassezia-safe balms before you blame the wax. And a reaction that stings on application and settles within a day of stopping is irritation, which is answered by removing a specific irritant rather than by rebuilding the whole formula.
Persistent, painful, nodular or scarring acne is a medical condition and no change of balm will resolve it. If lesions are deep, tender or leaving marks, or if the problem is affecting you day to day, see a doctor or dermatologist rather than working through oils. Nothing on this page is treatment, and the limits of what this site can tell you are set out in the safety disclaimer.
The suspects with something behind them
A few materials have earned their reputations, a few have inherited them, and it is worth knowing which is which.
| Material | What the evidence amounts to | Sensible move |
|---|---|---|
| Isopropyl myristate | The clearest case in the literature. Rated at the top of the classic scale and one of the materials the assay was built to catch. Reformulation away from it is documented industrial practice | Avoid in leave-on facial products if you are congestion-prone |
| Short-chain isopropyl esters generally | Family resemblance rather than individual data. Isopropyl palmitate and isopropyl isostearate carry similar reputations from the same era of testing | Treat as suspects, not as convictions |
| Coconut oil, virgin | Contested. Rated 4 on charts, from near-neat application. No good evidence at balm concentrations, and lauric acid is a usable substrate for Malassezia, which is a separate objection | Fine at low percentage in a rinse-off or a lip product, worth trialling before nightly facial use |
| Lanolin | Contested and frequently confused with allergy. The comedogenic reputation traces to older, less refined grades; modern medical grade material is a different specification | Judge on your own trial, and read the allergy question separately |
| Cocoa butter | Rated 4, which is the same score as coconut oil despite behaving nothing like it. That coincidence tells you more about the scale than the butter | Reasonable in body products, cautious on the face |
| Beeswax | Never tested. The safety literature covers irritation and sensitisation, not follicular plugging, so the 0 to 2 usually quoted is invented rather than measured | No reason to avoid, no evidence to reassure you either |
| Oxidised oils | Good mechanistic support. Oxidation products are irritating, and irritation around follicles looks like congestion | Buy small, store dark and cool, respect best-before dates |
| Fragrance and essential oils | Strong evidence for irritation and allergy, weak for comedogenicity. Different mechanism, similar-looking result | Remove first when troubleshooting, because it is cheap to test |
Two of those rows deserve expanding. Coconut oil produces more argument than everything else combined because both camps are describing something real: people do break out from it and people do use it happily, and the rating explains neither, since it was produced under conditions resembling nobody's routine. The formulation detail, including how differently fractionated material behaves, is in coconut oil in balms. And lanolin is routinely accused of two separate crimes at once. Its allergy reputation and its congestion reputation come from different literatures and different decades, and the first is examined properly in lanolin allergy explained.
Petrolatum, and why the vehicle argument matters
Petrolatum is the standing embarrassment for the theory that occlusive equals pore-clogging. It is the most strongly occlusive material in common cosmetic use, it is also the material chosen as the inert vehicle for patch testing precisely because it does so little on its own, and human comedogenicity work has generally not found it to be a meaningful comedogen. Meanwhile several light, dry, fast-absorbing esters rate at the top of the scale. If occlusivity drove comedogenicity, that pattern would run the other way round.
The vehicle point cuts deeper than a single ingredient. In the classic assays, materials were often applied dispersed in something, and what they were dispersed in changes how much reaches the follicular opening and how long it stays there. The same logic applies to your balm: a material at 6 percent, dissolved in a wax and oil matrix that is largely immobile at skin temperature, is not the same exposure as the neat material rubbed in daily. This is exactly why finished-product testing gives different answers from ingredient testing, and it is the reason the chart cannot be rescued by adjusting the numbers. The occlusion vocabulary itself is worth having straight, and it is defined in occlusive, emollient and humectant, with the wider material comparison in petrolatum and mineral oil.
It may be the mask, not the balm
Acne mechanica is a recognised entity, described by Mills and Kligman in 1975, in which lesions arise from mechanical factors rather than from anything applied. The recipe is occlusion plus friction plus heat and sweat, held against the skin for hours. The classic examples are helmet straps, violin chin rests, shoulder straps, headbands, phone handsets held to the jaw, and since 2020 the surgical or fabric face mask, where the pattern of lesions follows the edge of the mask with unhelpful precision.
This matters for balm users because a balm can be an innocent bystander that looks guilty. Apply a rich barrier product under a mask, a helmet or a wetsuit hood and you have supplied the occlusion component of a mechanism that was already half-built. The lesions are real and the balm contributed, but the fix is not necessarily a different balm. It may be a thinner film, a different application time, or a break in the friction. The dose question is covered in how much balm to apply, and the reasoning for barrier products under sustained occlusion sits in face balm.
Before you change product, change the timing for a fortnight. Apply the same balm at night only, and nothing under the mask, helmet or strap during the day. If the spots settle without the formula changing, you have identified friction and occlusion rather than an ingredient, and you have saved yourself a shopping trip.
The four week single area trial
This is the only test that answers the question for your skin. It is not difficult, but it fails if you run it loosely, and almost everyone runs it loosely.
- Stabilise everything else first. Two weeks with no other new products, no new actives, no change in cleanser. A trial run during a routine that is changing in three places tells you nothing at all.
- Pick one area and keep it. One side of the face is the cleanest design, because your two cheeks share your hormones, your pillow and your weather. If the product is for the whole face, apply it to one side only. If that is impractical, use one jaw or one temple, and mark which in your notes.
- Fix the dose. Same quantity, same number of applications a day, every day. A rice grain sized amount for a facial area is a reasonable standard. Varying the dose halfway through invalidates the comparison, and so does a heavy application on a bad day.
- Photograph properly on day 0, 14 and 28. Same light, same time of day, same distance, no flash, and both sides in the same frame. Skin looks different under bathroom downlights than at a window, and memory is a terrible instrument here.
- Count, do not judge. On each photograph day, count lesions on each side and write the number down. Two closed comedones versus five is a result. "It seems worse" is not.
- Run the full four weeks unless something forces you to stop. Two weeks catches the fast reactions, the acnegenic and the irritant, and misses comedones entirely, because comedo formation takes longer than that. Four weeks is the shortest honest trial for congestion.
- Stop early only for pain, swelling or spreading. A trial is not a reason to endure a reaction. Discomfort that is worsening is a stop signal, and a persistent one is a reason for an appointment.
A forearm patch is a different test with a different purpose, and it will not answer this question, since forearm skin is not facial skin and two days will not grow a comedo. It is still worth doing first for irritation and allergy, and the method is in how to patch test a balm.
When it is not the balm
Before you convict a product, rule out the confounders that produce identical timing by coincidence.
The menstrual cycle is the most common. Premenstrual flares are well recognised, typically in the week to ten days before a period, and they will land inside any four week trial at least once, which is one more reason for a same-person control on the other side of the face. Medications are next: corticosteroids in any form, lithium, some progestogens, certain anticonvulsants and isoniazid, and the epidermal growth factor receptor inhibitors used in oncology, which produce a characteristic papulopustular rash. If a flare started within weeks of a new prescription, that is a conversation for the prescriber, not a formulation problem.
Protein supplementation, particularly whey, is frequently blamed. The honest position is that the evidence is limited: case series and small studies suggest an association, with a plausible mechanism through insulin-like growth factor signalling, but this is not strong evidence and the effect size is unknown. It is worth a four week pause if you take it, which is cheap to test, rather than a certainty.
Then the boring ones, which are also the most common. A flare that had already begun before the product arrived, and would have appeared anyway. Heat, humidity or a new job with a hotter commute. Pillowcases, hats and helmets. Occlusion under a dressing. And oxidised product, which is a real change in the material rather than in you, described in rancidity and oxidation.
What to do with the result
If the trial side is clearly worse at day 28 and the difference survived a proper count, you have a product that does not suit you. That is a finished result and it needs no further explanation. You do not know which ingredient did it, and you may never know, because a balm has eight components and the interaction may involve several. If it matters enough, repeat the trial with a formula that differs by one ingredient, which is the only way to isolate a culprit, and use the label guide to find products that differ in one place rather than ten.
If both sides look the same, the product is fine for you, whatever any chart says about its ingredients, and you can stop reading about coconut oil. If you want a lower risk starting point for the next trial, rank candidates by residue rather than by rating: lighter, faster-finishing materials such as squalane and jojoba leave less on the surface, which is at least a property you can perceive, and the comparative data sit in carrier oils compared. Format is another free lever: a cleansing balm emulsified and rinsed within ninety seconds carries a fraction of the exposure of the same oils left on overnight.
Where this stops
Three honest limits. There is no test you can run at home that distinguishes a comedogenic response from a mild inflammatory one, so what you are really measuring is whether your skin is worse with the product than without it. That is a smaller claim than the ingredient charts make, and it is the only claim the method supports.
Second, a negative trial is valid for that product, that dose and that season. Sweat, humidity and sustained occlusion all change the answer, so a balm that behaved perfectly in March is not thereby cleared for August under a helmet. Third, none of this touches acne as a disease. A four week trial can tell you that a product is aggravating your skin. It cannot tell you why you have acne, and a formulation change is not a treatment. If the problem is more than cosmetic, the right next step is a clinician, and the reason a cosmetic cannot be sold as anything more is set out in cosmetic versus drug claims.
Frequently asked questions
Does lip balm cause acne?
It can contribute to spots around the mouth in some people, usually where balm is applied heavily and repeatedly and transfers onto the surrounding skin. Spots confined to the vermilion itself are unlikely to be acne at all, because the lip has almost no sebaceous follicles. If the pattern is a ring around the mouth rather than on the lip, suspect transfer, dose or an irritant such as flavour.
Are comedogenic ratings reliable?
Not as a prediction for an individual. They come from rabbit ear tests and small human studies on neat or near-neat materials, published between 1972 and 1989, and the charts in circulation disagree with each other and rarely state the concentration or the method used. Human testing of finished products has shown that a formula containing a rated ingredient is often not comedogenic itself.
How long does it take for a product to break me out?
It depends which reaction is happening. Irritant folliculitis appears within 24 to 72 hours, an inflammatory acnegenic response within about 3 to 10 days, and true comedones take 3 to 8 weeks because a plug has to form and become visible. That range is why a two week trial is not long enough to clear a product of causing congestion.
Is coconut oil going to break me out?
Possibly, and nobody can tell you in advance. It is commonly rated 4 out of 5 from testing near-neat material under occlusion, which resembles no real routine. Lauric acid is also usable by Malassezia yeasts, which is a separate objection from comedogenicity. Trial it on one side of the face for four weeks at a fixed dose, and treat a low percentage in a rinse-off product as a much lower risk.
Is petroleum jelly bad for acne-prone skin?
The evidence points the other way. Petrolatum is the most occlusive common cosmetic material and it is also the inert vehicle used in patch testing, and human comedogenicity work has not found it to be a significant comedogen. Occlusivity and comedogenicity are simply different properties. It can still feel unpleasantly heavy, which is a fair reason to avoid it, but that is not the same objection.
Can a mask or a helmet cause the spots I am blaming on my balm?
Yes. Acne mechanica is caused by occlusion, friction, heat and sweat rather than by an applied product, and it typically follows the outline of the mask, strap or chin rest. A rich balm applied underneath supplies the occlusion component, so both can contribute at once. Test it by applying at night only for two weeks and leaving the skin bare under the mask.
Should I patch test a balm on my arm first?
Do it, but know what it tells you. Two days on the forearm detects stinging, redness and some allergic reactions, which is worth catching before you put anything on your face. It cannot detect follicular congestion, because forearm skin has different follicles and a comedo needs weeks to form. The arm test screens for irritation, the four week facial trial answers the breakout question.
Sources and further reading
- Kligman, A. M., Mills, O. H., Acne cosmetica, Archives of Dermatology, 1972;106:843, PMID 4264346.
- Mills, O. H., Kligman, A. M., Acne mechanica, Archives of Dermatology, 1975;111:481.
- Mills, O. H., Kligman, A. M., A human model for assessing comedogenic substances, Archives of Dermatology, 1982;118:903, PMID 7138047.
- Draelos, Z. D., DiNardo, J. C., A re-evaluation of the comedogenicity concept, Journal of the American Academy of Dermatology, 2006;54:507, PMID 16488305.
- Fulton, J. E., Comedogenicity and irritancy of commonly used ingredients in skin care products, Journal of the Society of Cosmetic Chemists, 1989;40(6):321-333.
- US Food and Drug Administration, Cosmetics Labeling Claims, on terms that are not defined by regulation.
- National Institute for Health and Care Excellence, NG198: Acne vulgaris, management, United Kingdom.
Reviewed and updated 6 September 2026. Spotted an error? Tell us and we will fix and log it.